Unknown

Dataset Information

A real-world intention-to-treat analysis of a decade's experience of treatment of hepatitis C with interferon-based therapies.


ABSTRACT: Objectives: To assess the uptake of pegylated interferon (PegIFN) plus ribavirin (RBV)-based regimens in patients with hepatitis C virus (HCV) in a large, single-centre, real-world setting over 10 years. Methods: This was a single centre, retrospective analysis of data from patients who attended their first appointment for treatment of HCV genotype 1-3 between 2003 and 2013. Patients were stratified by HCV genotype. The total number of patients who attended their first appointment, incidence of patients who did not proceed to treatment and associated reasons, and incidence of patients treated were analysed. Sustained virological response (SVR) rates were also reported for all patient populations. Results: Overall, 1,132 patients attended their first appointment; 47.8%

SUBMITTER: Selvapatt N 

PROVIDER: S-EPMC5034792 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature